Seed startup

Who invested in Allergy Amulet

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$1.1Mraised across 1 round since 2016, from 1 source

Latest round
Seed, $1.1MOct 2016
Investors
1
See who backed them

The rounds

  1. Oct 2016
    Seed$1.1M

    Reported by XconomySEC filing: $880K sold, first sale Sept 2016

Founders and team

From the SEC filings it signed: 1 on the team.

  • Abigail BarnesExecutive Officer, Director, Promoteri

On the board, as filediDale NitschkeHalley GilbertNeil MixVictoria Grace

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Allergy Amulet as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Great Oaks Venture CapitalVC firmPer its own site
Gopher AngelsAngel networkPer its own site
Great North VenturesVC firmPer its own site
Lightship CapitalVC firmPer its own site
Dipalo VenturesVC firmPer its own site

Quick answers about Allergy Amulet

Who invested in Allergy Amulet?

Allergy Amulet's investors include Colle Capital Partners.

How much has Allergy Amulet raised?

Allergy Amulet has raised $1.1M across 1 round since 2016.

When did Allergy Amulet last raise?

Allergy Amulet's most recent round was a Seed of $1.1M in Oct 2016.

What was Allergy Amulet's biggest round?

Its most recent round, $1.1M in Oct 2016, is also its largest on record.

Who backed Allergy Amulet first?

Allergy Amulet's first round on record, in Oct 2016, was backed by Colle Capital Partners.

What stage is Allergy Amulet at?

Allergy Amulet's latest named round is a Seed, in Oct 2016.

Companies like Allergy Amulet

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.